Article
Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.
International journal of molecular sciences - 20 Aug 2015
Parmeggiani Francesco, Costagliola Ciro, Semeraro Francesco, Romano Mario R, Rinaldi Michele, Gallenga Carla Enrica, Serino Maria Luisa, Incorvaia Carlo, D'Angelo Sergio, De Nadai Katia, Dell'Omo Roberto, Russo Andrea, Gemmati Donato, Perri Paolo
Abstract excerpt
Macular degenerations represent leading causes of central blindness or low vision in developed countries. Most of these severe visual disabilities are due to age-related macular degeneration (AMD) and pathologic myopia (PM), both of which are frequently complicated by subfoveal choroidal neovascularization (CNV). Photodynamic therapy with verteporfin (PDT-V) is still employed for CNV treatment in selected cases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
